XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.48

+0.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (14032)	7/10/2000 7:59:50 PM
From: Cacaito	Read Replies (1) of 17367

Some in Yahoo, again, are promoting the excuse (falacy)that meningo data is not out cause they have to protect the journal publication and not bother the FDA. This is a falacy! xoma itself provides the example, xoma promoted without restraint (and success money wise)the pII trauma results in a selective positively BIAS way in the press ONE FULL year before the Journal of Trauma publication of the pII trial results! xoma knows that the data should be guard from the public to protect the stock price, they will try to hide the data as long as they could (for me forever is a good time frame)until they have some good news in something else. And the zovant combo will not be it. But, lets give it a nice name: XOVANT !

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next